[1] Torre, L. A. , F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, Global cancer statistics, 2012. CA Cancer J Clin, 2015. 65(2): p.87-108.
[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,0:1-31.
[3] Chen, W., R. Zheng, RD. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X. Q. Yu, and J. He, Cancer statisticsin China, 2015. CA Cancer J Clin, 2016.
[4] American Cancer Society. Colorectal Cancer Facts and Figures 2011-2013. Atlanta: American Cancer Society, 2011.
[5] Imperiale TF, RansohoffDF, Itzkowitz SH, et a1. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average risk population. N Engl J Med, 2004, 351: 2704-2714.
[6] LIEBERMAN D A. Screening, surveillance, and prevention of colorectal cancer[J]. Gastrointest Endosc Clin N Am, 2008, 18: 595-605.
[7] Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. Plos One 2012; 7(2): 1-12.
[8] Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, et a1. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 2016; 7:11215.
[9] Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J,et al. Circular RNAs are abundant, converved, and associated with ALU repeats. RNA 2013; 19(2): 141-57.
[10] Danan M, Schwartz S,Edelheit S, Sorek R. Transcriptome-wide discovery of circular RNAs in Archaea. Nucleic Acids Res 2012; 40(7): 3131-42.
[11] W.W. Du, L. Fang, W. Yang, N. Wu, F.M. Awan, Z. Yang, B.B. Yang, Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 24 (2017) 357e370.
[12] J. Wang, H. Li, CircRNA circ_0067934 silencing inhibits the proliferation, migration and invasion of NSCLC cells and correlates with unfavorable prognosis in NSCLC. Eur. Rev. Med. Pharmacol. Sci. 22 (2018) 3053e3060.
[13] Y. Xu, Y. Yao, X. Zhong, K. Leng, W. Qin, L. Qu, Y. Cui, X. Jiang, Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Biochem. Biophys. Res. Commun. 496 (2018) 455-461.
[14] Huang G, Zhu H, Shi Y, et al. Circ-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-catenin pathway[J]. PloS One, 2015; 10(6): e0131225.
[15] Agarwal V, Bell GW, Nam J, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife, 4:e05005, (2015). eLife Lens view.
[16] Pasquinelli AE., MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet, 2012 13: 271–282.
[17] Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome biology 11, R90, 2010.
[18] Nathan Wong and Xiaowei Wang (2015) miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Research. 43(D1):D146-152.
[19] Chih-Hung Chou, Sirjana Shrestha, Chi-Dung Yang, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions, Nucleic Acids Research, Volume 46, Issue D1, 4 January 2018, Pages D296–D302.
[20] Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T: Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 27: 431-432, 2011.
[21] Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki RA: The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183, 2007.
[22] Kanehisa M: The KEGG database. Novartis Found Symp 247: 91-252, 2002.
[23] Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
[24] Chen Z, Ren R, Wan D, Wang Y et al. Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene 2019 Aug;38(32):6017-6034. PMID: 31300733.
[25] Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210, 2002.
[26] Li JH, et al.starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data , Nucleic Acids Res. 2014 Jan;42:D92-7.
[27] Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP, Chakravarthi BVSK and Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017 Aug;19(8):649-658.
[28] Zhang, Y. et al. Circular intronic long noncoding RNAs. Molecular cell 51, 792–806, (2013).
[29] Jeck WR, Sharpless NE: Detecting and characterizing circular RNAs. Nat. Biotechnol. 2014, 32, 453–461.
[30] Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE: Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013, 19, 141–157.
[31] Li, J. et al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications. American journal of cancer research 5, 472–480 (2015).
[32] Wang, Y. et al. Circular RNAs in human cancer. Molecular cancer 16, 25, (2017).
[33] Lu, D. & Xu, A. D. Mini Review: Circular RNAs as Potential Clinical Biomarkers for Disorders in the Central Nervous System. Frontiers in genetics 7, 53, (2016).
[34] Wang, K. et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. European heart journal 37, 2602–2611, (2016).
[35] Xia, W. et al. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Scientifc reports 6, 35576, (2016).
[36] Li, P. et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clinica chimica acta; international journal of clinical chemistry 444, 132–136, (2015).
[37] Qin, M. et al. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer biomarkers: section A of Disease markers 16, 161–169, (2016).
[38] Shang, X. et al. Comprehensive Circular RNA Profling Reveals Tat hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development. Medicine 95, e3811, (2016).
[39] Wang, X. et al. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical signifcances. International journal of clinical and experimental pathology 8, 16020–16025 (2015).
[40] Xuan, L. et al. CircularRNA: a novel biomarker for progressive laryngeal cancer. American journal of translational research 8, 932–939 (2016).
[41] Song, X. et al. Circular RNA profle in gliomas revealed by identifcation tool UROBORUS. Nucleic acids research 44, e87, (2016).
[42] Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338.
[43] Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature 2013, 495, 384–388.
[44] Hansen TB, Wiklund ED, Bramsen JB, et al. MiRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J.2011, 30, 4414–4422.
[45] Chen CY, Sarnow P: Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science 1995, 268, 415–417.
[46] Perriman R, Ares M. Jr. Circular mRNA can direct translation of extremely long repeating-sequence proteins in vivo. RNA 1998, 4, 1047–1054.
[47]Wang C, Qi S, Xie C, Li C, Wang P, Liu D. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p. J Gynecol Oncol. 2018;29(6):e99. doi:10.3802/jgo.2018.29.e99.
[48] Falzone L, Candido S, Salemi R, et al. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer. Oncotarget. 2016;7(45):72758–72766. doi:10.18632/oncotarget.11805.